I am a
Home I AM A Search Login

Papers of the Week


2023 Jan 20


Medicine (Baltimore)


102


3

Bone metastatic carcinoma with EGFR amplification and mutation: A case report and literature review.

Authors

Du H-J, Chen F-F, Liu Y, Zhou Y
Medicine (Baltimore). 2023 Jan 20; 102(3):e32615.
PMID: 36701708.

Abstract

Mutations in the epidermal growth factor receptor (EGFR) gene are highly prevalent in non-small cell lung cancer, while rare in other cancers. Primarily it's hardly present in bone metastases from cancer of unknown primary (BMCUP). Currently, no specific treatment options for bone metastases from unknown primary cancers exist.